VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > 🌟 Annual Angiopro Sales Meeting 2024 🌟

<< Previous

Bullboard Posts

Next >>

Post by jopatcloon Jul 26, 2024 10:36am

97 Views

Post# 36149731

🌟 Annual Angiopro Sales Meeting 2024 🌟

Interesting

Annual Angiopro Sales Meeting 2024

This week, our dynamic sales team gathered for our yearly Sales Meeting, a time to reflect on our achievements, forge strategies for the future, and enhance our collaborative skills.

We were also thrilled to host Szabolcs Osvth, CEO, and Olga N. from the Kinepict Health Ltd. Team, diving deeper into their innovative software that's setting new standards in medical imaging.
A great opportunity for hands-on learning and exploring how these advancements can benefit patient care.

Angiopro SalesMeeting2024 Teamwork Innovation Kinepict MedicalImaging Healthcare